Record title
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors
Record identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d6d1da80e61d43f995ed1d456acbc093
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6d1da80e61d43f995ed1d456acbc093
Share
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors
About this item
Full title
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors
Author / Creator
Publisher
England: BMJ Publishing Group LTD
Journal title
Journal for immunotherapy of cancer, 2020, Vol.8 (1), p.e000530
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d6d1da80e61d43f995ed1d456acbc093
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d6d1da80e61d43f995ed1d456acbc093
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6d1da80e61d43f995ed1d456acbc093
Other Identifiers
ISSN
E-ISSN
DOI
